BSE procedure guidelines for the clinical application of stress echocardiography, recommendations for performance and interpretation of stress echocardiography

A report of the British Society of Echocardiography Policy Committee

H Becher, J Chambers, K Fox, R Jones, G J Leech, N Masani, M Monaghan, R More, P Nihoyannopoulos, H Rimington, R Senior, G Warton

British Society of Echocardiography, c/o British Cardiac Society, 9 Fitzroy Square, London W1T 5HW, UK

Correspondence to:
Correspondence to:
Dr Harald Becher
John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK; harald.becher@orh.nhs.uk

Abbreviations: ACS, acute coronary syndrome; BSE, British Society of Echocardiography; CAD, coronary artery disease; DTI, Doppler tissue imaging; LBBB, left bundle branch block; LV, left ventricular; MRI, magnetic resonance imaging

Keywords: contrast echocardiography; dobutamine stress; guidelines; imaging standard; stress echocardiography

The first 150 words of the full text of this article appear below.

The British Society of Echocardiography (BSE) procedure guidelines for the clinical application of stress echocardiography, recommendations for performance and interpretation of stress echocardiography are presented here.

The objective of guidelines is to enhance appropriateness of practice, improve quality of care, lead to better patient outcomes, and help authorities to decide on the approval of diagnostic or therapeutic procedures. For patients with coronary artery disease (CAD), one of the greatest challenges of our heath care system, a variety of diagnostic procedures is available at varying financial burdens. In order to improve cost effectiveness precise guidelines are needed to advise physicians.¹

Stress echocardiography has become a valuable method for cardiovascular stress testing. It plays a crucial role in the initial detection of coronary artery disease, in determining prognosis and in therapeutic decision making.^2,3 These recommendations refer to the use of stress echocardiography to assess myocardial ischaemia or viability in patients with coronary . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Karabinos, I., Karvouni, E., Chiotinis, N., Papadopoulos, A., Simeonidis, P., Tsolas, O., Katritsis, D. (2007). Acute changes in N-terminal pro-brain natriuretic peptide induced by dobutamine stress echocardiography. Eur J Echocardiogr 8: 265-274 [Abstract] [Full Text]  
• Olszewski, R., Timperley, J., Cezary, S., Monaghan, M., Nihoyannopoulis, P., Senior, R., Becher, H. (2007). The clinical applications of contrast echocardiography. Eur J Echocardiogr 8: s13-s23 [Full Text]  
• Aggeli, C., Giannopoulos, G., Misovoulos, P., Roussakis, G., Christoforatou, E., Kokkinakis, C., Brili, S., Stefanadis, C. (2007). Real-time three-dimensional dobutamine stress echocardiography for coronary artery disease diagnosis: validation with coronary angiography. Heart 93: 672-675 [Abstract] [Full Text]  
• Tsutsui, J M, Lario, F C., Fernandes, D R, Kowatsch, I, Sbano, J C, Franchini Ramires, J A, Mathias, W Jr (2005). Safety and cardiac chronotropic responsiveness to the early injection of atropine during dobutamine stress echocardiography in the elderly. Heart 91: 1563-1567 [Abstract] [Full Text]